ISSCR News
The ISSCR Forms Embryo Models Working Group
Since the ISSCR released its May 2021 update to the Guidelines for Stem Cell Research and Clinical Translation, research with stem cell-based embryo models has evolved rapidly. During the extensive conversations leading up to the 2021 guidelines update, many of the embryo models that are being used today did not exist. The speed of embryo model research has resulted in new challenges for oversight committees, policymakers, funders, and journal editors grappling with how to assess the unique aspects of the science and the associated ethical and regulatory issues.
ISSCR Holds First Academia Briefing Meeting with the European Medicines Agency
On 10 April 2024, the ISSCR held its first Academia Briefing Meeting with the European Medicines Agency (EMA). The meeting was organized by ISSCR’s Manufacturing, Clinical Translation, and Regulatory (MCTR) Committee and included invitees to present to the agency on two topics: recommendations for the manufacturing of PSC banks as starting materials for allogeneic PSC-based therapies and genetic characterization of human PSCs. Following the meeting, both parties confirmed the importance of regular meetings to ensure a bi-directional sharing of knowledge to advance the development of cellular therapies.
New Podcast Episode. Going Out on a LIM: Rethinking the Role of LMX1A in Patterning Dopaminergic Neurons
This episode of The Stem Cell Report will discuss the process of directing stem cells to acquire the proper identity, an essential step in the development of effective and durable cell replacement therapies. Specifically, we will talk about the process of directing cells into a ventral mesencephalic dopaminergic fate for treating Parkinson’s disease.
Year in Review: 2023-2024 Message from the President
The past year has been a time of remarkable scientific advancement and contributions from our growing ISSCR community. The ISSCR now represents nearly 5,000 individuals in more than 80 countries. Nearly half our members are students and postdocs, who are the future of our field. And while our field is moving fast, so is your society.
Janet Rossant Named as New Stem Cell Reports Editor-in-Chief Starting in 2025
The International Society for Stem Cell Research (ISSCR) announces the appointment of Janet Rossant, President of the Gairdner Foundation and Senior Scientist Emeritus at the Hospital for Sick Children, Canada as the next Stem Cell Reports Editor-in-Chief beginning 1 January 2025. Dr. Rossant will take over the position held by Martin Pera, The Jackson Laboratory, USA, for nearly six years.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .